Pharmacie by Medi-Market Group - Zemst
0670.966.420 · rovalta.com · 27/09/2026
NORMAL SITUATION
Pharmacie by Medi-Market Group - Zemst
Company — Normal situation.
Strike-off: 25 juin 2026
Financial year 2025 · Closed on 31/12/2025
Net result20,9 k €+9,0 %over 1 year
Gross margin71,4 k €-5,7 %over 1 year
Equity-111,2 k €+15,8 %over 1 year
Overview
Identity
Source · BCE/KBOPharmacie by Medi-Market Group - Zemst is a Public limited company incorporated in 2017.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0670.966.420
- Incorporation
- 10/02/2017
- Legal form
- Public limited company
- Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 313
Signals
ProfitablePositive cashflowPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 71,4 k € | -5.7% | 75,8 k € | -2.6% | 77,8 k € | +55.8% | 49,9 k € | -5.3% | 52,7 k € |
| EBITDA | 71 k € | -5.7% | 75,3 k € | -2.1% | 76,9 k € | +60.3% | 48 k € | -8.3% | 52,4 k € |
| Operating result | 42 k € | -9.0% | 46,2 k € | +0.9% | 45,8 k € | +361% | 9,9 k € | -12.0% | 11,3 k € |
| Net result | 20,9 k € | +9.0% | 19,2 k € | +12.7% | 17 k € | +532% | 2,7 k € | -61.2% | 6,9 k € |
| Balance sheet | |||||||||
| Equity | -111,2 k € | +15.8% | -132,1 k € | +12.7% | -151,4 k € | +10.1% | -168,4 k € | +1.6% | -171,1 k € |
| Total assets | 609,7 k € | +8.1% | 563,9 k € | +10.0% | 512,4 k € | +11.1% | 461,3 k € | -32.2% | 679,9 k € |
| Cash | 0 € | -100% | 8,9 k € | +306% | 2,2 k € | +62.2% | 1,4 k € | -78.2% | 6,2 k € |
| Debts | 720,9 k € | +3.6% | 696,1 k € | +4.9% | 663,8 k € | +5.4% | 629,7 k € | -26.0% | 850,9 k € |
| Other | |||||||||
| Workforce | – | – | – | 0,0 ETP | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20251 active · 7 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/12/2020 | 00 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 31/12/2020 | 00 | |
| Director | since 30/12/2020 | 00 | |
| Director | 09/02/2017 → 09/06/2022 | ||
| Director | 09/02/2017 → 09/06/2022 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 01/07/2025 | 11/07/2024 | 29/08/2023 | 30/03/2023 | 28/03/2022 |
| General meeting | 29/06/2026 | 27/06/2025 | 01/07/2024 | 25/08/2023 | 30/03/2023 | 28/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 01/07/2026 | French | |
| Abridged model | 31/12/2024 | 27/06/2025 | 01/07/2025 | French | |
| Abridged model | 31/12/2023 | 01/07/2024 | 11/07/2024 | French | |
| Abridged model | 31/12/2022 | 25/08/2023 | 29/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/03/2023 | 30/03/2023 | French | |
| Abridged model | 31/12/2020 | 28/03/2022 | 28/03/2022 | French | |
| Abridged model | 31/12/2019 | 18/12/2020 | 18/12/2020 | French | |
| Abridged model | 31/12/2018 | 17/07/2019 | 23/07/2019 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 7 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/12/2020 | 00 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 31/12/2020 | 00 | |
| Director | since 30/12/2020 | 00 | |
| Director | 09/02/2017 → 09/06/2022 | ||
| Director | 09/02/2017 → 09/06/2022 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other02/07/2026ASSEMBLEE GENERALE EXTRAORDINAIRE
- Restructuring07/05/2026Projet de fusion - Pouvoirs
- Other09/09/2025Renouvellement du mandat du commisaire - Pouvoirs
- Mandates06/02/2023DEMISSIONS, NOMINATIONS
- Mandates05/08/2021DEMISSIONS, NOMINATIONS
- Mandates26/01/2021ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates07/02/2020DEMISSIONS, NOMINATIONS
- Mandates23/09/2019DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202520,9 k €↑
- 2024Annual accounts 202419,2 k €↑
- 2023Annual accounts 202317 k €↑
- 2022Annual accounts 20222,7 k €↓
- 2021Annual accounts 20216,9 k €↑
- 2018Annual accounts 2018-182,3 k €
- 10/02/2017IncorporationPublic limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Cicéron 7, 1140 Evere | CBE until 25/06/2026 | CBE |
| Avenue Cicéron 7, 1140 Evere | accounts 2021 → 2025 | Accounts 2025 · 2026-00243504 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Pharmacie by Medi-Market Group - Zemst | CBE until 25/06/2026 | CBE |
| Pharmacie by Medi-Market Group - Zemst | accounts 2018 → 2025 | Accounts 2025 · 2026-00243504 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.